• The Journal of the Korean dental association
• /
• v.47 no.10
• /
• pp.637-646
• /
• 2009

양성 종양(benign tumor)을 언급하기에 앞서 과오종(hamartoma) 및 과다 형성(hyperplasia)과의 차이를 구분할 필요가 있다. 양성 종양은 기원조직과 유사한 조직이 이상 증식하는 것으로 서서히 성장하지만 일반적으로 치료하기 전까지 이상 증식을 지속하는 진성 신생물을 일컫는다. 이에 비해 과오종은 정상 조직이 무질서하게 과증식하는 것으로 일정기간 후에는 성장을 멈추기 때문에 진성 신생물로 간주하지 않는다. 그러나 일부 과오종이 양성 종양에 포함되기도 하는데, 예를 들어 치아종은 정상적인 치성 조직의 성장이 완료되는 시기와 거의 동일한 시기에 성장을 멈추지만 양성 종양으로 분류된다. 과다 형성은 조직의 세포가 정상적인 배열 양상을 보이면서 세포의 수가 증가하는 것으로 지속적인 성장 양상을 보이지만 그 성장이 제한적이므로 양성 종양과는 구별된다. 양성 종양은 일반적으로 무통성으로 서서히 성장하기 때문에 종양의 크기가 증가하여 안면 종창이나 동통 등을 유발하는 경우에 발견될 수 있으며, 방사선검사에서 우연히 발견되기도 한다. 방사선검사는 병소의 위치, 범위, 특징 및 병소와 인접 해부학적 구조와의 관계 등 많은 방사선학적 진단 정보를 제공한다. 일부 종양은 방사선사진에서 매우 특징적인 소견을 나타내기 때문에 방사선학적 소견으로 예비 진단을 할 수 있을 정도의 진단정보를 제공하기도 하는 반면 어떤 종양들은 방사선사진에서 관찰되는 소견이 매우 유사하여 진단에 어려움을 주기도 한다. 따라서 종양의 확진을 위해서는 생검이 필수적이며, 방사선검사는 반드시 생검에 앞서 진행되어야만 정확한 방사선학적 진단을 할 수 있다. 양성 종양은 각각의 특징적인 방사선학적인 소견을 나타내지만 일반적으로 관찰되는 양성 종양의 특징이 존재하므로 이러한 일반적인 특징을 관찰하여 병소가 양성인지 악성인지를 감별할 수 있다. 첫째, 양성 종양은 대개 호발하는 부위가 있으므로 종양의 발생부위는 감별 진단을 하는 데 매우 중요하다. 일반적으로 치성 병소는 치아가 형성되는 하악관 상방의 치조돌기에서, 혈관성 및 신경성 병소는 하악관 내에서, 연골성 종양은 하악과두와 같이 연골세포가 잔존되어 있는 부위에서 발생하는 경우가 많다. 둘째, 양성 종양은 대체로 명확한 경계와 피질골성 변연을 보이며, 종종 병소가 결체조직으로 둘러싸여 있어 병소 주위에 방사선투과성 띠가 관찰되기도 한다. 셋째, 양성 종양은 일반적으로 인접 주위 조직에 압력을 가하면서 서서히 성장하기 때문에 인접 치아의 변위 또는 흡수, 피질골의 비박, 팽융 등의 소견을 보이며 피질골의 천공은 드물다. 방사선학적으로 양성 종양의 병소 내부는 방사선투과상으로 관찰되거나, 방사선불투과상으로 관찰되거나, 방사선투과상과 방사선불투과상이 혼재된 상으로 관찰된다. 저자는 이 지면에서 이러한 방사선학적 특징을 기초로 하여 구강악안면영역에 발생하는 양성 종양을 분류하고 각각의 특징에 대해 살펴보고자 한다.

• Radiation Oncology Journal
• /
• v.12 no.1
• /
• pp.9-16
• /
• 1994

Hypothesis that hypoxic tumors should be more responsive to the addition of preferential hypoxic cell cytotoxin SR 4233 (tirapazamine) to fractionated irradiation was tested in the mouse SCCVll carcinoma and RIF-1 sarcoma, Model of hypoxic tumor was established using the tumor bed effect: tumors growing in the preirradiated tissue (preirradiated tumors) were more hypoxic than tumors growing in the unirradiated tissue (unirradiated tumors). When the tumors reached a mean volume of 100 $mm^{3}$, both unirradiated and preirradiated tumors were treated with a fractionated course of 6${\times}$2 Gy in 3 days or 8${\times}$2.5 Gy in 4 days with SR 4233 (0.08 mmol/kg/injection) given 30 minutes before each irradiation or without SR 4233. Compared to the unirradiated tumors, hypoxic preirradiated tumors were approximately 5 times more resistant to fractionated irradiation alone but were approximately 5 times more responsive to SR 4233. Addition of SR 4233 Potentiated the effect of fractionated irradiation in both unirradiated and preirradiated tumors. Potentiation in the preirradiated tumors was morequal to or greater than that in the unirradiated tumors and seemed to be higher for more fractionated treatment. We confirm the hypothesis in a transplantable mouse tumor. Present results suggest that radioresistance of some hypoxic tumors can be overcome with hypoxic cytotoxin.

• Progress in Medical Physics
• /
• v.4 no.1
• /
• pp.17-21
• /
• 1993

근접방사선치료는 방사성동위원소를 종양에 밀착시키거나 또는 종양내에 직접 삽입하여 치료하는 방법으로서 종양에는 일시에 많은 선량을 주는 반면 주위 정상조직에는 선량을 최소화시킬 수 있는 장점이 있다. 따라서 근래에 들어 종양치료에 있어서 외부방사선치료와 병행하여 근접방사선치료를 시행하는 병원이 증가하고 있다. 그러나 근접방사선치료는 방출 방사선의 에너지가 낮고, 대부분 짧은 반감기를 가지며, 소형의, 수 mCi에서 수Ci 정도의 방사능을 가진 방사성동위원소들을 인체에 직접 삽입하는 것으로 정확한 선량 분포를 위해서는 방사성동위원소의 방사능량, 위치, 분포 등의 정확성 확보가 절실히 요구된다. 따라서 이 논문은 근접방사선치료시스템의 QA프로그램 개발을 위하여 작성하였다.

• Radiation Oncology Journal
• /
• v.3 no.1
• /
• pp.69-73
• /
• 1985

• Radiation Oncology Journal
• /
• v.8 no.2
• /
• pp.169-176
• /
• 1990

Radiotherapy result was analyzed in 23 children with retinoblastoma treated in Seoul National University Hospital from 1980 to 1987. Three ($17\%$) had bilateral tumor at diagnosis. Among 20 children with unilateral retinoblastoma 13 children got radiotherapy after enucleation, 2 were treated with radiotherapy alone, and 5 were delivered with radiotherapy after relapse. Of 15 non-recurrent unilateral tumors, there were 5 stage II children, 8 stage III, and 2 stage IV by staging system proposed by St. Jude Children's Research Hospital. Chemotherapy was combined when resection margin of the optic nerve was positive or when malignant cell was found in CSF. Of 12 children who completed radiotherapy, local or distant failure was not found but 2 cases of relapse at the contralateral retina were observed. Their 5 year survival rate was $82.2\%$. Another case of contralateral relapse was detected in children who was treated with radiotherapy alone. Thus overall frequency of the bilateral disease was $33\%$. Prognosis of recurrent tumors were so poor that no cases of CR was obtained and that 3 year survival rate was $20\%$. Two of 3 bilateral cases at diagnosis were in NED status. Complication were sunken orbit only. Result of radiotherapy was so good in early stage or small bulk tumor that treatment delay after diagnosis must not be allowed.

• Radiation Oncology Journal
• /
• v.18 no.2
• /
• pp.120-126
• /
• 2000

Purpose : Tumor hypoxia can be overcome with hypoxic cytotoxin. In mouse tumor, tirapazamine's efficacy of the potentiating radiation effect was tested by the tumor oxygenation status combined with hype facti on ated rad iotherapy .:The control and hypoxic mouse tumors we established by inoculation of RIF-1 tumor cells into the normal or previously irradiated back and thigh of C3H mice. When the tumors reached a proper size, both the control and hypoxic tumors were given hypefractionated treatments (8fractions/4 days) with saline (0.02 ml/g), tirapazamin (0.08 mM/0.02 ml/kg), irradiation (2.5 Gy), irradiation combined with tirapazamine given 30 minutes prior to each irradiation. The response was evaluated by the growth delay assay by measuring tumor size from day 0 (12 hrs prior to the first fractionation) to the day when the volume had 4-fold increase or cross sectional area had 2-fold increase. Results : Overall growth pattern showed that tirapazamine Potentiated radiation effect in back and thigh tumors grew in the normal and preirradiated tumor bed. With growth delay assay using reference point of initial tumor volume or cross sectional area, tirapazamine potentiated radiation effect 1.9 times for the control and 2.4 times for the hypoxic tumors in back, and 1.85 times for the control and 1.6 times for the hypoxic tumors. With reference of 4-fold increase of the initial volume or 2-fold increase of the cross sectional area, tirapazamine potentiated radiation effect 1.48 times for the control and 2.02 times for the hypxic tumors in back, and 1.85 times for the control and 1.6 times for the hypoxic tumors. Conclusions : Present result indicated that radiation response of hypoxic tumors was potentiated by tirapazamine in the back or thigh tumors grew in the control or preirradiated tumor bed, and potentiation of the hypoxic tumors was eDual to or greater than that of the control tumors in the back or thigh.

• Progress in Medical Physics
• /
• v.20 no.3
• /
• pp.167-173
• /
• 2009

As the radiotherapy technique development, the needs for using of medical electronic chart in the department of radiation oncology is growing. However, the complexity of affairs of radiation oncology make it difficult to develop a electronic medical chart. In this study, we introduce the electronic medical chart developed by domestic hospital. The function and example of electronic medical chart designed as radiation treatment progress was showed and the future study was presented.

• The Journal of Korean Society for Radiation Therapy
• /
• v.35
• /
• pp.23-31
• /
• 2023

Purpose: The purpose of this study is to evaluate the usefulness of Non-Treat Functionality Volumetric Modulated Arc Therapy(NTF-VMAT) and Treat Functionality VMAT(TF-VMAT) treatment plans in reducing the low-dose area during radiation therapy for patients with multiple metastatic cancers. Materials and Methods: The study was conducted on an Arccheck phantom, treatment planning target locations were set in pairs at intervals of 2 cm, 4 cm, and 6 cm on the X, Y, and Z axes. Based on these location settings, the volume of the low-dose area in NTF-VMAT and TF-VMAT was measured and compared. Results: The results of the study showed that, within a prescription dose range of 10% ~ 70%, the difference in low-dose area volumes across each axis was as follows: On the X-axis, there was a maximum difference of -47.6% and a minimum difference of -2.2%. On the Y-axis, there was a maximum difference of -17.5% and a minimum difference of -7.3%. The Z-axis showed a maximum difference of -39.7%, with the smallest difference being -6.8%. Conclusion: In radiation therapy for patients with multiple metastatic cancers, the TF-VMAT treatment plan was able to reduce the low-dose area by 10-40% compared to NTF-VMAT. This suggests that utilizing Treat Functionality, which includes the Island block technique, improves dose distribution and minimizes side effects, making it beneficial for the treatment of patients with multiple metastatic cancers.

• Radiation Oncology Journal
• /
• v.20 no.2
• /
• pp.100-107
• /
• 2002

Purpose : The aim of this retrospective study was to assess the treatment results of 30 patients with pineal region tumors who were underwent radiation therapy under the diagnosis by either CT or MRI. There was no histological verification. We analyzed the prognostic factors that have a significant effect on the overall survival (OS) and disease free survival (DFS) rates. Materials and Methods : A total 30 patients with pineal region tumors were treated between March 1983 and August 1995. After a trial radiation therapy of $20\~30\;Gy/2\~3$ weeks, the patients were evaluated for their clinical response and radiological response by either CT or MRI and the final treatment direction was then decided. According to their response to the trial radiation therapy and the involved site, radiation treatment was given in various fields i.e., local, ventricle, whole brain and craniospinal field. The radiation dose ranged from 40.8 to 59.4 Gy (Median 50.4 Gy). The median follow up was 36.5 months $(4\~172\;months)$. Results : An improvement or stability in the clinical symptoms was observed in 28 patients $(93.3\%)$ after the trial RT. Nineteen patients $(63.3\%)$ showed a partial or complete response by CT or MRI. The two-year and five-year survival rates of the patients were $66.7\%$ and $55.1\%$, respectively. No significant difference in the survival rates according to the degree of the radiological response was abserved after the trial RT. The results of univariate analysis showed that age, the primary site, the performance status $(KPS\geq70)$, the degree of response after completing RT and the RT field were significant prognostic factors affecting the survival and disease free survival rates (p<0.05). Conclusion : The clinical and histological characteristics of pineal region tumors are quite complex and diverse. Therefore, it is difficult to predict the histological diagnosis and the possibility of radiocurability only with the initial response to RT. We think that the development of less invasive histological diagnostic techniques and tailored treatment to the histological type of each tumor are needed.

• Journal of radiological science and technology
• /
• v.45 no.6
• /
• pp.553-560
• /
• 2022

The purpose of this study is to evaluate the clinical risk according to the applicator heterogeneity, mislocation, and tissue heterogeneity correction through a dose verification program during brachytherapy of cervical cancer. We performed image processing with MATLAB on images acquired with CT simulator. The source was modeled and stochiometric calibration and Monte-Carlo algorithm were applied based on dwell time and location to calculate the dose, and the secondary cancer risk was evaluated in the dose verification program. The result calculated by correcting for applicator and tissue heterogeneity showed a maximum dose of about 25% higher. In the bladder, the difference in excess absolute risk according to the heterogeneity correction was not significant. In the rectum, the difference in excess absolute risk was lower than that calculated by correcting applicator and tissue heterogeneity compared to the water-based calculation. In the femur, the water-based calculation result was the lowest, and the result calculated by correcting the applicator and tissue heterogeneity was 10% higher. A maximum of 14% dose difference occurred when the applicator mislocation was 20 mm in the Z-axis. In a future study, it is expected that a system that can independently verify the treatment plan can be developed by automating the interface between the treatment planning system and the dose verification program.